A. Poll

发表

Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result

A. Eisen, S. Narod, K. Metcalfe, 2021, Annals of Surgical Oncology.

The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer

A. Eisen, S. Narod, K. Metcalfe, 2020, Breast Cancer Research and Treatment.

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

W. Foulkes, L. Salmena, J. Lubiński, 2012, Breast Cancer Research.

Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study

M. Akbari, A. Eisen, S. Narod, 2020, Annals of Surgical Oncology.

A prospective study of breast cancer risk in relatives of BRCA1/BRCA2 mutation carriers.

S. Narod, A. Poll, Erica Rowan, 2007, Journal of medical genetics.

Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer.

E. Warner, S. Narod, A. Poll, 2011, Breast.

Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial

A. Kiss, S. Narod, K. Metcalfe, 2016, Genetics in Medicine.

A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing

S. Narod, K. Metcalfe, A. Poll, 2013, British Journal of Cancer.

Patient satisfaction and cancer‐related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2

S. Narod, A. Poll, P. Sun, 2010, Clinical genetics.

A BRCA1 mutation is not associated with increased indicators of oxidative stress.

S. Narod, J. Kotsopoulos, P. Ainsworth, 2008, Clinical breast cancer.

Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers

Stephanie A Cohen, O. Olopade, B. Karlan, 2021, Breast Cancer Research and Treatment.

Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning

A. Eisen, S. Narod, K. Metcalfe, 2021, Breast Cancer Research and Treatment.

Relationship between Caffeine and Levels of DNA Repair and Oxidative Stress in Women with and without a BRCA1 Mutation

S. Narod, J. Kotsopoulos, P. Ainsworth, 2015, Lifestyle Genomics.

Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation

B. Rosen, S. Narod, A. O'Connor, 2007, Clinical genetics.

Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel

S. Narod, J. Kotsopoulos, K. Metcalfe, 2016, Breast Cancer Research and Treatment.

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

W. Foulkes, L. Salmena, J. Lubiński, 2012, Breast Cancer Research.

Analysis of PALB2/FANCN-associated breast cancer families

Petra M. Nederlof, Jorge S. Reis-Filho, David M. Livingston, 2007, Proceedings of the National Academy of Sciences.

The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation

O. Olopade, P. Møller, W. Foulkes, 2013, Breast Cancer Research and Treatment.

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study

Stephanie A Cohen, F. Couch, O. Olopade, 2016, British Journal of Cancer.

Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study.

D. Horsman, W. Foulkes, Z. Aziz, 2008, Cancer research.

Rapid progression of prostate cancer in men with a BRCA2 mutation

P Ghadirian, F. Couch, D. Horsman, 2008, British Journal of Cancer.

Does family history predict the age at onset of new breast cancers in BRCA1 and BRCA2 mutation‐positive families?

A. Eisen, S. Narod, P. Ainsworth, 2010, Clinical genetics.

Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation

D. Horsman, S. Narod, A. Poll, 2008, British Journal of Cancer.

Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.

S. Narod, K. Metcalfe, A. Poll, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women

W. Foulkes, A. Robidoux, S. Narod, 2007, Breast Cancer Research.

Toenail selenium status and DNA repair capacity among female BRCA1 mutation carriers

S. Narod, J. Kotsopoulos, P. Ainsworth, 2010, Cancer Causes & Control.

DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers

S. Narod, J. Kotsopoulos, P. Ainsworth, 2006, British Journal of Cancer.

Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation

W. Foulkes, B. Rosen, A. Eisen, 2008, Clinical genetics.

Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test?

A. Eisen, S. Narod, K. Metcalfe, 2022, Cancer medicine.

Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening

K. Hughes, S. Narod, K. Metcalfe, 2012, Breast Cancer Research and Treatment.

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation

F. Couch, O. Olopade, P. Møller, 2023, Breast Cancer Research and Treatment.

Patient satisfaction and cancer‐related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2

K. Metcalfe, A. Poll, M. Llacuachaqui, 2010, Clinical genetics.

Does family history predict the age at onset of new breast cancers in BRCA1 and BRCA2 mutation‐positive families?

A. Eisen, S. Narod, A. Poll, 2010, Clinical genetics.